Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Dahut

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Cancer Journal (Sudbury, Mass.)|March 25, 2022
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and CareFatima Karzai, William L Dahut
American Journal of Therapeutics|July 22, 2004
Chemotherapy for prostate cancer: finally an advance!James Gulley, William L Dahut
Urology|January 30, 2004
Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patientJames Gulley, William L Dahut
Expert Review of Anticancer Therapy|May 10, 2005
Clodronate in the prevention and treatment of skeletal metastasisJames Gulley, William L Dahut
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2009
Angiogenesis inhibition in the treatment of prostate cancerRavi A Madan, William L Dahut
Cancer Journal (Sudbury, Mass.)|February 28, 2008
The role of angiogenesis inhibitors in prostate cancerJeanny B Aragon-Ching, William L Dahut
Current Molecular Pharmacology|July 21, 2009
VEGF inhibitors and prostate cancer therapyJeanny B Aragon-Ching, William L Dahut
Cancer Therapy|August 23, 2007
Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?Jeanny B Aragon-Ching, William L Dahut
Update on Cancer Therapeutics|September 24, 2009
Anti-angiogenesis approach to genitourinary cancer treatmentJeanny B Aragon-Ching, William L Dahut
Drug Discovery Today. Therapeutic Strategies|September 17, 2011
Novel Androgen Deprivation Therapy (ADT) in the Treatment of Advanced Prostate CancerJeanny B Aragon-Ching, William L Dahut
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Cancer Journal (Sudbury, Mass.)|March 25, 2022
Lessons From the Impact of the COVID-19 Pandemic at the National Cancer Institute: Cancer Research and CareFatima Karzai, William L Dahut
American Journal of Therapeutics|July 22, 2004
Chemotherapy for prostate cancer: finally an advance!James Gulley, William L Dahut
Urology|January 30, 2004
Novel approaches to treating the asymptomatic hormone-refractory prostate cancer patientJames Gulley, William L Dahut
Expert Review of Anticancer Therapy|May 10, 2005
Clodronate in the prevention and treatment of skeletal metastasisJames Gulley, William L Dahut
Anti-Cancer Agents in Medicinal Chemistry|September 2, 2009
Angiogenesis inhibition in the treatment of prostate cancerRavi A Madan, William L Dahut
Cancer Journal (Sudbury, Mass.)|February 28, 2008
The role of angiogenesis inhibitors in prostate cancerJeanny B Aragon-Ching, William L Dahut
Current Molecular Pharmacology|July 21, 2009
VEGF inhibitors and prostate cancer therapyJeanny B Aragon-Ching, William L Dahut
Cancer Therapy|August 23, 2007
Chemotherapy in Androgen-Independent Prostate Cancer (AIPC): What's next after taxane progression?Jeanny B Aragon-Ching, William L Dahut
Update on Cancer Therapeutics|September 24, 2009
Anti-angiogenesis approach to genitourinary cancer treatmentJeanny B Aragon-Ching, William L Dahut
Drug Discovery Today. Therapeutic Strategies|September 17, 2011
Novel Androgen Deprivation Therapy (ADT) in the Treatment of Advanced Prostate CancerJeanny B Aragon-Ching, William L Dahut
Pageof 15